CN105168688A - Traditional Chinese medicine for treating rheumatic arthritis - Google Patents
Traditional Chinese medicine for treating rheumatic arthritis Download PDFInfo
- Publication number
- CN105168688A CN105168688A CN201510594722.9A CN201510594722A CN105168688A CN 105168688 A CN105168688 A CN 105168688A CN 201510594722 A CN201510594722 A CN 201510594722A CN 105168688 A CN105168688 A CN 105168688A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- rheumatic arthritis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating rheumatic arthritis. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 5.5-7.5 parts of herba taxilli, 2-4 parts of morinda officinalis, 5-7 parts of centella aslatlca urban, 15-20 parts of rhizoma acori graminei, 4-6 parts of ephedra, 2-4 parts of saposhnicovia divaricata, 5-6 parts of ligusticum wallichii, 2-4 parts of honeysuckle stems, 5-6 parts of dipsacus asperoids, 2-4 parts of Japanese raspberry root, 5-6 parts of prepared frankincense, 1-2 parts ofangelica pubescens, 4-5 parts of phryma leptostachya, 20-25 parts of cassia twig, 7-10 parts of radix angelicae, 2-4 parts of rhizoma corydalis, 4-6 parts of obscured homalomena rhizome, 2-4 parts of nidus vespae, 4-5 parts of solanum cathayanum, 2-3 parts of pine bark and 1-3 parts of caragana root. According to the dialectic analysis of rheumatic arthritis, the medicinal materials are impacted one another and synergized to achieve the effects of relieving arthralgia by relaxing muscles and tendons, clearing heat, expelling pus, drying dampness, eliminating cold, warming channels, promoting qi circulation and the like, so that the traditional Chinese medicine has a remarkable effect for treating rheumatic arthritis, has the characteristics of good curative effect, short course of treatment and small toxic and side effect, and is worthy of clinical popularization.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of rheumatic arthritis, belong to the field of Chinese medicines.
Background technology
Rheumatic arthritis is a kind of common acute or chronic ICT, can recurrent exerbation involve heart; Clinical with joint and muscle migrans miserable, heavily work, pain is for feature, rheumatic arthritis is one of main manifestations of rheumatic fever, mainly with febris acuta and arthralgia onset, typical performance is slight or moderate heating, migratory polyarthritis, affected joints mostly is the large joint such as knee joint, ankle, shoulder, elbow, wrist, is commonly transferred to another joint by a joint; pathological changes local presents red, swollen, scorching hot, severe pain, and some patients also has several joint to fall ill simultaneously; At present, the medicines such as doctor trained in Western medicine many uses glucocorticoids, immunosuppressant are treated this disease, though there is certain curative effect, therapeutic effect is unsatisfactory, and such medicine also has suitable toxic and side effects, and life-time service is larger to patient's harm.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of rheumatic arthritis.
The present invention adopts following technical scheme:
The Chinese medicine for the treatment of rheumatic arthritis, the weight portion of its constitutive material is: Herba Taxilli 5.5-7.5, Radix Morindae Officinalis 2-4, Herba Calthae Membranaceae 5-7, Rhizoma Acori Graminei 15-20, Herba Ephedrae 4-6, Radix Saposhnikoviae 2-4, Rhizoma Chuanxiong 5-6, Caulis Lonicerae 2-4, Radix Dipsaci 5-6, Herba Rubi parvifolii 2-4, Olibanum (processed) 5-6, Radix Angelicae Pubescentis 1-2, Herba speranskiae tuberculatae 4-5, Ramulus Cinnamomi 20-25, Radix Angelicae Dahuricae 7-10, Rhizoma Corydalis 2-4, Rhizoma Homalomenae 4-6, honeycomb room 2-4, Solanum lyratum Thunb. 4-5, Cortex Pini 2-3, caragana root 1-3.
The Chinese medicine for the treatment of rheumatic arthritis, the weight portion of its constitutive material is: Herba Taxilli 6.5, Radix Morindae Officinalis 3, Herba Calthae Membranaceae 6, Rhizoma Acori Graminei 18, Herba Ephedrae 5, Radix Saposhnikoviae 3, Rhizoma Chuanxiong 5.5, Caulis Lonicerae 3, Radix Dipsaci 5.5, Herba Rubi parvifolii 3, Olibanum (processed) 5.5, Radix Angelicae Pubescentis 1.5, Herba speranskiae tuberculatae 4.5, Ramulus Cinnamomi 22, the Radix Angelicae Dahuricae 8, Rhizoma Corydalis 3, Rhizoma Homalomenae 5, honeycomb room 3, Solanum lyratum Thunb. 4.5, Cortex Pini 2.5, caragana root 2.
Consumption and usage: take each raw material by the weight portion of constitutive material, put into the Chinese liquor 1L of 52 DEG C, and after soaking 2-3 month, can cure after daily medicated wine 30-50ml, general 2-3 month, long-term taking also can be conducive to health.
Beneficial effect of the present invention:
Chinese medicine of the present invention is according to the dialectical Analyses of rheumatism, all medicines interact, synergism, there is the effects such as arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus, damp eliminating cold expelling, warming the meridian and promoting blood circulation, treatment rheumatic arthritis Be very effective, have good effect, short treating period, feature that toxic and side effects is little, clinic is promoted.
Detailed description of the invention
Embodiment 1: the Chinese medicine for the treatment of rheumatic arthritis, the weight portion (g) of its constitutive material is: Herba Taxilli 6.5, Radix Morindae Officinalis 3, Herba Calthae Membranaceae 6, Rhizoma Acori Graminei 18, Herba Ephedrae 5, Radix Saposhnikoviae 3, Rhizoma Chuanxiong 5.5, Caulis Lonicerae 3, Radix Dipsaci 5.5, Herba Rubi parvifolii 3, Olibanum (processed) 5.5, Radix Angelicae Pubescentis 1.5, Herba speranskiae tuberculatae 4.5, Ramulus Cinnamomi 22, the Radix Angelicae Dahuricae 8, Rhizoma Corydalis 3, Rhizoma Homalomenae 5, honeycomb room 3, Solanum lyratum Thunb. 4.5, Cortex Pini 2.5, caragana root 2.
Consumption and usage: take each raw material by the weight portion of constitutive material, put into the Chinese liquor 1L of 52 DEG C, and after soaking 2-3 month, can cure after daily medicated wine 30-50ml, general 2-3 month, long-term taking also can be conducive to health.
Model case:
Case 1: the Qin, female, 52 years old, suffer from rheumatic arthritis for many years, deeply pull the devil by the tail, often feel leg joint, shoulder joint swells and ache, joint stuffiness, takes Western medicine and for several times loses curative effect, after take Chinese medicine of the present invention, use by consumption and usage, after one month, arthritis pain obviously alleviates, and continues to strengthen treatment two months, arthroncus, pain are eliminated, follow up a case by regular visits to without recurrence.
Case 2: Cui so-and-so, man, 67 years old, suffer from rheumatic arthritis many decades, whole body arthralgia is obvious, colder then aggravation, then be unable to leave the bed time serious, take Chinese medicine of the present invention, use by consumption of the present invention and usage, behind more than ten skies, the obvious sensory effect of patient is obvious, and arthralgia obviously alleviates, and continues to take so far afterwards, healthy and strong, general joint is without any discomfort sense.
Claims (2)
1. treat a Chinese medicine for rheumatic arthritis, it is characterized in that the weight portion of its constitutive material is: Herba Taxilli 5.5-7.5, Radix Morindae Officinalis 2-4, Herba Calthae Membranaceae 5-7, Rhizoma Acori Graminei 15-20, Herba Ephedrae 4-6, Radix Saposhnikoviae 2-4, Rhizoma Chuanxiong 5-6, Caulis Lonicerae 2-4, Radix Dipsaci 5-6, Herba Rubi parvifolii 2-4, Olibanum (processed) 5-6, Radix Angelicae Pubescentis 1-2, Herba speranskiae tuberculatae 4-5, Ramulus Cinnamomi 20-25, Radix Angelicae Dahuricae 7-10, Rhizoma Corydalis 2-4, Rhizoma Homalomenae 4-6, honeycomb room 2-4, Solanum lyratum Thunb. 4-5, Cortex Pini 2-3, caragana root 1-3.
2. the Chinese medicine for the treatment of rheumatic arthritis according to claim 1, is characterized in that the weight portion of its constitutive material is: Herba Taxilli 6.5, Radix Morindae Officinalis 3, Herba Calthae Membranaceae 6, Rhizoma Acori Graminei 18, Herba Ephedrae 5, Radix Saposhnikoviae 3, Rhizoma Chuanxiong 5.5, Caulis Lonicerae 3, Radix Dipsaci 5.5, Herba Rubi parvifolii 3, Olibanum (processed) 5.5, Radix Angelicae Pubescentis 1.5, Herba speranskiae tuberculatae 4.5, Ramulus Cinnamomi 22, the Radix Angelicae Dahuricae 8, Rhizoma Corydalis 3, Rhizoma Homalomenae 5, honeycomb room 3, Solanum lyratum Thunb. 4.5, Cortex Pini 2.5, caragana root 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510594722.9A CN105168688A (en) | 2015-09-18 | 2015-09-18 | Traditional Chinese medicine for treating rheumatic arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510594722.9A CN105168688A (en) | 2015-09-18 | 2015-09-18 | Traditional Chinese medicine for treating rheumatic arthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105168688A true CN105168688A (en) | 2015-12-23 |
Family
ID=54891443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510594722.9A Withdrawn CN105168688A (en) | 2015-09-18 | 2015-09-18 | Traditional Chinese medicine for treating rheumatic arthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105168688A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1839952A (en) * | 2005-12-22 | 2006-10-04 | 清华大学深圳研究生院 | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis |
CN1911292A (en) * | 2006-08-25 | 2007-02-14 | 苏国友 | Medicated wine for treating rheumatismal arthritis and rheumatoid arthritis, and its prepn. method |
CN102309560A (en) * | 2010-06-30 | 2012-01-11 | 杨永江 | Chinese medicinal decoction for treating rheumatic arthritis |
CN104547790A (en) * | 2015-01-09 | 2015-04-29 | 周恩昌 | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof |
-
2015
- 2015-09-18 CN CN201510594722.9A patent/CN105168688A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1839952A (en) * | 2005-12-22 | 2006-10-04 | 清华大学深圳研究生院 | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis |
CN1911292A (en) * | 2006-08-25 | 2007-02-14 | 苏国友 | Medicated wine for treating rheumatismal arthritis and rheumatoid arthritis, and its prepn. method |
CN102309560A (en) * | 2010-06-30 | 2012-01-11 | 杨永江 | Chinese medicinal decoction for treating rheumatic arthritis |
CN104547790A (en) * | 2015-01-09 | 2015-04-29 | 周恩昌 | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
刘钟华: "施今墨痹证治验", 《中国社区医师》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
CN104771740A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
CN104587242A (en) | Medicinal liquor for treating rheumatic arthritis | |
CN103860675A (en) | Composition for treating rheumatoid arthritis | |
CN103705671A (en) | Formula of traditional Chinese medicine for treating sciatica | |
CN101073633A (en) | Chinese-herb medicinal preparation for treating various rheumatalgia, neuralgia and hyperosteogeny | |
CN103330798A (en) | Traditional Chinese medicinal preparation for treating rheumatisms | |
CN105168688A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
CN103585589A (en) | Medicine for treating chronic rheumatoid arthritis | |
CN103961656B (en) | A kind of Chinese medicine treating Chronic venous insufficiency | |
CN103550736B (en) | Traditional Chinese medicine for treating blood stasis and channel blockage symptom type amenorrhea | |
CN104922443A (en) | External-use patch for treating rheumatic arthritis | |
CN105031426A (en) | External medicinal liquor for treating burns and scalds | |
CN104127571A (en) | Medicinal liquor for treating rheumatoid arthritis | |
CN104623278A (en) | External traditional Chinese medicine for treating heat toxin type acne | |
CN104027581A (en) | External applied traditional Chinese medicament for treating bone fracture | |
CN103285289A (en) | Traditional Chinese medicine for treating arthralgia | |
CN102846847B (en) | Traditional Chinese medicine for treating lumbago | |
CN104001115A (en) | Traditional Chinese medicine for treating hands and feet numbness | |
CN102743544A (en) | Traditional Chinese medicine for treating qi and blood stasis and obstruction type rheumatic arthralgia | |
CN101703712A (en) | Chinese medicinal composition for treating rheumatoid sciatica | |
CN105311490A (en) | Traditional Chinese medicine capable of treating rheumatic osteoarthritis caused by sprain injury | |
CN104922360A (en) | External use traditional Chinese medicine for treating senile muscle and bone pain | |
CN108671153A (en) | Treat the Chinese medicine of rheumatic arthritis | |
CN105168682A (en) | External traditional Chinese medicine for treating rheumatic arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20151223 |
|
WW01 | Invention patent application withdrawn after publication |